Sonoma Pharmaceuticals Inc (SNOA) — Cash Flow Reinvestment Rate
Sonoma Pharmaceuticals Inc (SNOA) has a Cash Flow Reinvestment Rate of 0.09x as of March 2025, reinvesting $49.00K (capex $2.00K plus investments $-47.00K) from operating cash flow of $565.00K. See free cash flow generation of Sonoma Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sonoma Pharmaceuticals Inc Cash Flow Reinvestment Rate (2013–2013)
Historical reinvestment intensity for Sonoma Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see Sonoma Pharmaceuticals Inc (SNOA) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Sonoma Pharmaceuticals Inc (2013–2013)
Year-by-year capital reinvestment analysis for Sonoma Pharmaceuticals Inc. See how financially flexible is Sonoma Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 0.22x | $257.00K | $1.15 Million | $257.00K | — |